UnitedHealth Group Incorporated $UNH Shares Purchased by Gradient Investments LLC

Key Points

• Gradient Investments LLC increased its stake in UnitedHealth Group by 11.0%, owning a total of 123,184 shares valued at approximately $38.43 million.
• Analysts have varied opinions on UnitedHealth Group, with price targets ranging from $198.00 to $358.95 and a consensus rating of "Moderate Buy".
• UnitedHealth Group declared a quarterly dividend of $2.21, reflecting an annualized basis dividend of $8.84 and a dividend yield of 2.5%.

Gradient Investments LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 123,184 shares of the healthcare conglomerate's stock after buying an additional 12,217 shares during the period. Gradient Investments LLC's holdings in UnitedHealth Group were worth $38,430,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Citizens National Bank Trust Department lifted its stake in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Caitlin John LLC lifted its stake in shares of UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after purchasing an additional 111 shares in the last quarter. Meredith Wealth Planning acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at about $258,000. Finally, Novem Group acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $854,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Bank of America boosted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Robert W. Baird reissued an "underperform" rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Royal Bank Of Canada reduced their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Barclays lifted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Finally, KeyCorp dropped their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $358.95.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $352.61 on Monday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $319.35 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 2.30 and a beta of 0.45. The business has a 50 day simple moving average of $291.98 and a 200-day simple moving average of $368.31.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm posted $6.80 earnings per share. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.